China Pharma Holdings, Inc. SEC filings CPHI

China Pharma Holdings, Inc. has 426 filings in SEC EDGAR's recent list, going back to Feb 15, 2000. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 22, 2026 (material agreement, other events). The company's fiscal year ends on December 31.

China Pharma Holdings, Inc. SEC filings
Form Description Filed Period
PRE 14A Preliminary proxy statement Oct 30, 2026 Oct 30, 2026
DEF 14A Proxy statement Nov 14, 2025 Dec 30, 2025
PRE 14A Preliminary proxy statement Nov 4, 2025 Nov 4, 2025
DEF 14A Proxy statement Nov 12, 2024 Dec 22, 2024
PRE 14A Preliminary proxy statement Nov 1, 2024 Nov 1, 2024
DEF 14A Proxy statement Nov 7, 2023 Dec 18, 2023
PRE 14A Preliminary proxy statement Oct 27, 2023 Oct 27, 2023
DEF 14A Proxy statement Nov 14, 2022 Dec 28, 2022
PRE 14A Preliminary proxy statement Nov 4, 2022 Dec 28, 2022
DEFA14A Additional proxy material Nov 15, 2021 —
DEF 14A Proxy statement Nov 15, 2021 Dec 27, 2021
DEFA14A Additional proxy material Nov 16, 2020 —
DEF 14A Proxy statement Nov 16, 2020 Dec 28, 2020
DEFA14A Additional proxy material Nov 6, 2019 —
DEF 14A Proxy statement Nov 6, 2019 Dec 19, 2019
DEFA14A Additional proxy material Oct 25, 2018 —
DEF 14A Proxy statement Oct 25, 2018 Dec 5, 2018
DEFA14A Additional proxy material Nov 3, 2017 —
DEF 14A Proxy statement Nov 3, 2017 Dec 14, 2017
DEFA14A Additional proxy material Oct 28, 2016 —
DEF 14A Proxy statement Oct 28, 2016 Dec 8, 2016
DEFA14A Additional proxy material Oct 29, 2015 —
DEF 14A Proxy statement Oct 29, 2015 Dec 8, 2015
DEF 14A Proxy statement Nov 20, 2014 Dec 29, 2014
DEFA14A Additional proxy material Nov 6, 2013 —
DEF 14A Proxy statement Nov 6, 2013 Dec 16, 2013
DEF 14A Proxy statement Nov 19, 2012 Dec 21, 2012
PRE 14A Preliminary proxy statement Nov 9, 2012 Nov 14, 2012
DEFA14A Additional proxy material Nov 23, 2011 —
DEF 14A Proxy statement Nov 14, 2011 Dec 22, 2011
DEFA14A Additional proxy material Nov 12, 2010 —
DEF 14A Proxy statement Nov 12, 2010 Dec 22, 2010
DEF 14C Information statement May 5, 2010 May 5, 2010
PRE 14C China pharma holdings, inc. Apr 1, 2010 Mar 29, 2010
DEF 14C Information statement Sep 23, 2009 Sep 23, 2009
PRE 14C Filing Sep 15, 2009 Sep 3, 2009
PRE 14C Filing Sep 3, 2009 Sep 3, 2009
DEF 14C Information statement Jun 25, 2009 Jun 25, 2009
PRE 14C Filing Jun 22, 2009 Apr 28, 2009
DEF 14C Information statement Jul 11, 2008 Jul 11, 2008
PRE 14C Filing Jun 27, 2008 Feb 1, 2008
DEF 14C Information statement Mar 28, 2006 Mar 28, 2006
PRE 14C Ts electronics, inc. - schedule 14c Jan 25, 2006 Jan 26, 2006
PRE 14C Filing Oct 9, 2003 Jun 30, 2003
PRE 14C Filing Aug 20, 2003 Aug 20, 2003

Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPHI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hainan Province, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1106644
Former names
TS ELECTRONICS INC (until May 4, 2006); SOFTSTONE INC (until Aug 18, 2003); SOFTSTONE INC /DE/ (until Jan 27, 2003); KILKENNY ACQUISITION CORP (until Mar 30, 2001)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.